$IPSC
Century Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.46
▲+14.03%+$0.180
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCentury Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Flagged at $1.22 at 09:39 AM on Oct 08, then ran to $1.46 +20% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is IPSC up today? It is at $1.46 (+14.03%), and our scanner flagged it 31 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IPSC spikes, and full due diligence on IPSC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IPSC 31 times in the last 30 days. Create a free account to track $IPSC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IPSC from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystCNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 3299.6% of the tradeable float is in play - 3299.6% has already been sold.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
506,915,533 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carr Douglas Officer | Sold (automatic/other) | -2K | sold 0.3% | 503K | $3K at $1.93 | Sep 14, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -3K | sold 0.5% | 509K | $5K at $1.93 | Sep 14, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -14K | sold 0.4% | 3.63M | $27K at $1.94 | Sep 11, 26 |
Carr Douglas Officer | Sold (automatic/other) | -254 | sold <0.1% | 505K | $521 at $2.05 | Sep 8, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -534 | sold 0.1% | 512K | $1K at $2.05 | Sep 8, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -463 | sold <0.1% | 3.63M | $977 at $2.11 | Sep 4, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -31K 0.02% of company | sold 0.9% | 3.63M | $60K at $1.92 | Aug 14, 26 |
Carr Douglas Officer | Sold (automatic/other) | -275 | sold <0.1% | 505K | $545 at $1.98 | Aug 3, 26 |
Carr Douglas Officer | Sold (automatic/other) | -2K | sold 0.3% | 505K | $4K at $2.23 | Jun 12, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -3K | sold 0.5% | 512K | $6K at $2.23 | Jun 12, 26 |
Cowan Chad Officer | Sold (automatic/other) | -358 | sold <0.1% | 1.18M | $802 at $2.24 | Jun 11, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -14K | sold 0.4% | 3.67M | $31K at $2.24 | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on IPSC from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
IPSC last traded at $1.46, up 14.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Century Therapeutics, Inc. Common Stock (IPSC) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IPSC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IPSC 31 times in the last 30 days.
IPSC (Century Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $264M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IPSC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IPSC discussion
Sign in to ask a question or join the discussion.